SEARCH
Serum Institute gets DCGI's nod to manufacture Sputnik V in India
India Today
2021-06-04
Views
5
Description
Share / Embed
Download This Video
Report
The Drugs Controller General of India (DCGI) granted permission to Serum Institute of India to manufacture Russian Covid-19 vaccine Sputnik V in India.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x81r72s" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:01
Serum Institute seeks DCGI nod to manufacture Covid-19 vaccine Sputnik V in India
05:29
COVID-19 Vaccine Update: Sputnik V To Undergo Trial In India, Dr Reddys Gets DCGI Approval, Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials
01:18
‘Serum Institute Seeks Permission To Manufacture Russian COVID19 Vaccine Sputnik-V’
01:18
‘Serum Institute Seeks Permission To Manufacture Russian COVID19 Vaccine Sputnik-V’
03:00
Serum Institute Of India’s Covovax Gets Emergency Use Listing Nod From World Health Organization
49:49
India's Covid-19 tally crosses 50 lakh-mark; Serum Institute gets nod to restart Oxford vaccine trial; more
05:29
COVID-19 Vaccine: Sputnik V To Undergo Trial In India, Serum Institute To Start Intranasal Trials
02:32
Corona Vaccine: India में तेजी से बनेगी Sputnik V, Serum Institute के साथ बड़ी डील | वनइंडिया हिंदी
01:17
Serum Institute of India ने DCGI से मांगी Sputnik V के निर्माण की इजाजत | Corona Vaccine
03:50
Oxford COVID-19 Vaccine ‘70% Effective’, Serum Institute Chief Says India Could Give Nod By Year-End
06:16
Serum Institute Seeks Emergency Use Nod For Covishield In India
03:50
Oxford COVID-19 Vaccine ‘70% Effective, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
